Back to search
FDAFDA · Food and drugs·Recall number D-0285-2022

Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-159-30

Published December 22, 2021 · Recall initiated: December 1, 2021

Summary

FDA records drug Class III recall D-0285-2022, published December 22, 2021 and initiated December 1, 2021. Recalling firm: Torrent Pharma Inc.; Status: Terminated; Reported quantity: 27,312 Bottles; Lot: Batch: BZ74G001 Exp. 12/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent; Hydrochlorothiazide

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Torrent Pharma Inc.
Distributor
Nationwide USA
Lot
Batch: BZ74G001 Exp. 12/2021.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-159-30 recalled?

Yes. FDA published recall D-0285-2022 on December 22, 2021. Reported hazard: Superpotent; Hydrochlorothiazide

What should I do if I have this product?

Voluntary: Firm initiated · Letter